Primary |
Hypertension |
25.0% |
Migraine |
18.2% |
Blood Pressure Increased |
12.5% |
Arrhythmia |
6.8% |
Long Qt Syndrome |
6.8% |
Ventricular Tachycardia |
4.5% |
Heart Rate Increased |
3.4% |
Blood Pressure |
2.3% |
Hypothyroidism |
2.3% |
Insomnia |
2.3% |
Mitral Valve Prolapse |
2.3% |
Portal Hypertension |
2.3% |
Syncope |
2.3% |
Tachycardia |
2.3% |
Angina Pectoris |
1.1% |
Antiplatelet Therapy |
1.1% |
Atrial Fibrillation |
1.1% |
Blood Pressure Abnormal |
1.1% |
Cardiac Murmur |
1.1% |
Diabetes Mellitus |
1.1% |
|
Hypoglycaemic Unconsciousness |
13.5% |
Urticaria |
7.7% |
Completed Suicide |
5.8% |
Dysuria |
5.8% |
Left Ventricular Dysfunction |
5.8% |
Malaise |
5.8% |
Product Quality Issue |
5.8% |
Convulsion |
3.8% |
Drug Ineffective |
3.8% |
Drug Intolerance |
3.8% |
Feeling Abnormal |
3.8% |
Glossodynia |
3.8% |
Heart Rate Increased |
3.8% |
Hypoglycaemia |
3.8% |
Hypoglycaemic Seizure |
3.8% |
Hypotension |
3.8% |
Palpitations |
3.8% |
Product Substitution Issue |
3.8% |
Sinus Arrest |
3.8% |
Syncope |
3.8% |
|
Secondary |
Product Used For Unknown Indication |
35.8% |
Hypertension |
12.6% |
Atrial Fibrillation |
6.3% |
Drug Use For Unknown Indication |
5.7% |
Blood Pressure Increased |
4.4% |
Atrial Tachycardia |
3.8% |
Heart Rate Increased |
3.8% |
Portal Hypertension |
3.1% |
Suicide Attempt |
3.1% |
Cardiac Disorder |
2.5% |
Essential Tremor |
2.5% |
Non-small Cell Lung Cancer |
2.5% |
Bipolar Disorder |
1.9% |
Crohn's Disease |
1.9% |
General Anaesthesia |
1.9% |
Migraine |
1.9% |
Nodal Arrhythmia |
1.9% |
Retroperitoneal Fibrosis |
1.9% |
Agitation |
1.3% |
Anaesthesia Reversal |
1.3% |
|
Completed Suicide |
11.4% |
Dizziness |
11.4% |
Vomiting |
9.1% |
Cardio-respiratory Arrest |
4.5% |
Drug Ineffective |
4.5% |
Extrasystoles |
4.5% |
Gastrointestinal Haemorrhage |
4.5% |
Large Intestine Polyp |
4.5% |
Loss Of Consciousness |
4.5% |
Neuralgia |
4.5% |
Palpitations |
4.5% |
Reaction To Drug Excipients |
4.5% |
Renal Tubular Necrosis |
4.5% |
Respiratory Arrest |
4.5% |
Sinus Arrest |
4.5% |
Toxicity To Various Agents |
4.5% |
Abnormal Dreams |
2.3% |
Agitation |
2.3% |
Bradycardia |
2.3% |
Cardiac Failure Acute |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
25.3% |
Hypertension |
10.8% |
Drug Use For Unknown Indication |
10.1% |
Hepatitis C |
9.2% |
Depression |
4.7% |
Gastrooesophageal Reflux Disease |
4.3% |
Migraine |
3.9% |
Pain |
3.9% |
Prophylaxis |
3.8% |
Blood Cholesterol Increased |
3.3% |
Diabetes Mellitus |
2.9% |
Rheumatoid Arthritis |
2.8% |
Hepatic Neoplasm Malignant |
2.4% |
Anxiety |
2.3% |
Atrial Fibrillation |
2.2% |
Insomnia |
1.8% |
Headache |
1.7% |
Multiple Sclerosis |
1.6% |
Type 2 Diabetes Mellitus |
1.5% |
Osteoporosis |
1.5% |
|
Weight Increased |
11.1% |
Vomiting |
10.0% |
Nausea |
7.7% |
Weight Decreased |
6.6% |
Varices Oesophageal |
5.5% |
Drug Ineffective |
5.3% |
White Blood Cell Count Decreased |
4.9% |
Dyspnoea |
4.4% |
Fatigue |
4.4% |
Flushing |
4.4% |
Headache |
4.4% |
Urinary Tract Infection |
4.0% |
Somnolence |
3.8% |
Wheezing |
3.8% |
Pyrexia |
3.5% |
Diarrhoea |
3.3% |
Thyroid Disorder |
3.3% |
Wrong Technique In Drug Usage Process |
3.3% |
Pain |
3.1% |
Pain In Extremity |
3.1% |
|
Interacting |
Product Used For Unknown Indication |
30.0% |
Blood Cholesterol Increased |
15.0% |
Smoking Cessation Therapy |
15.0% |
Wolff-parkinson-white Syndrome |
15.0% |
Dyspnoea |
10.0% |
Off Label Use |
5.0% |
Stress Echocardiogram |
5.0% |
Syncope |
5.0% |
|
Drug Interaction |
50.0% |
Cardiac Flutter |
16.7% |
Extrasystoles |
16.7% |
Traumatic Intracranial Haemorrhage |
16.7% |
|